CLINICAL_TRIALS
trial_result
· 2017-11-01
Clinical Trial Update: NOA-12: BIBF1120 and R-RT in Glioblastoma [Phase 1, Phase 2]
Summary
A Phase 1/2 trial evaluating BIBF1120 (nintedanib) with radiotherapy for glioblastoma multiforme has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prof. Dr. Wolfgang Wick | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: TERMINATED